These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions. Stenersen TC; Dabelsteen E APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523 [TBL] [Abstract][Full Text] [Related]
3. Distribution of histo-blood group antigens in cervical and uterine endometrium. Stubbe Teglbjaerg C; Ravn V; Mandel U; Dabelsteen E APMIS Suppl; 1991; 23():100-6. PubMed ID: 1883633 [TBL] [Abstract][Full Text] [Related]
4. Aberrant glycosylation in oral malignant and premalignant lesions. Dabelsteen E; Clausen H; Mandel U J Oral Pathol Med; 1991 Sep; 20(8):361-8. PubMed ID: 1941653 [TBL] [Abstract][Full Text] [Related]
5. Cell surface carbohydrates as prognostic markers in human carcinomas. Dabelsteen E J Pathol; 1996 Aug; 179(4):358-69. PubMed ID: 8869281 [TBL] [Abstract][Full Text] [Related]
6. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901 [TBL] [Abstract][Full Text] [Related]
7. Epithelial isoantigens A, B and H in oral carcinomas. Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275 [No Abstract] [Full Text] [Related]
8. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens. Dabelsteen E; Clausen H; Holmstrup P; Reibel J APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339 [TBL] [Abstract][Full Text] [Related]
9. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies. Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100 [TBL] [Abstract][Full Text] [Related]
10. Oncofetal fibronectins in oral carcinomas: correlation of two different types. Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273 [TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia? Chen YK; Hsue SS; Lin LM Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192 [TBL] [Abstract][Full Text] [Related]
12. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677 [TBL] [Abstract][Full Text] [Related]
13. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera. van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301 [TBL] [Abstract][Full Text] [Related]
14. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors. Skovlund VR APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838 [TBL] [Abstract][Full Text] [Related]
16. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions. Shabana AH; Ivanyi L; Kramer IR Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238 [TBL] [Abstract][Full Text] [Related]
17. Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region? Bryne M; Gravdahl C; Koppang HS; Kjaerheim A; Dabelsteen E J Pathol; 1995 Feb; 175(2):237-42. PubMed ID: 7738720 [TBL] [Abstract][Full Text] [Related]
18. Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. Jones J; Sugiyama M; Watt FM; Speight PM J Pathol; 1993 Feb; 169(2):235-43. PubMed ID: 8445489 [TBL] [Abstract][Full Text] [Related]
19. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267 [TBL] [Abstract][Full Text] [Related]
20. Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage. Hague A; Eveson JW; MacFarlane M; Huntley S; Janghra N; Thavaraj S J Pathol; 2004 Oct; 204(2):175-82. PubMed ID: 15376256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]